Peritoneal carcinomatosis from non‐gynecologic malignancies

By Babak Sadeghi, C. Arvieux, O. Glehen, A. Beaujard, M. Rivoire, J. Baulieux, E. Fontaumard, A. Brachet, J. Caillot, J. Faure and 5 more. Cancer, 2000

1,236 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Reproductive Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/5a0e2f864489ddc0f9ebe7f54ec6b58a9d829c83

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Elias
2. F. Quénet
3. F. Gilly
4. S. Bruin
5. F. Boutitie
6. J. Bereder
7. B. Mansvelt
8. E. Levine

Citations in the corpus

• 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer (2008, background): “This was a major improvement relative to the only 6 months survival time known from the literature.(2,11,12)”
• Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. (2004, background): “The three principal studies dedicated to the natural history of peritoneal carcinomatosis from colorectal cancer confirmed this poor prognosis, with a median survival ranging between 6 and 8 months and no 5-year survivors.(2,6,7) The carcinomatosis extent was found to be the principal prognostic ind”
• Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. (2010, background): “Peritoneal dissemination or carcinomatosis from colorectal carcinoma is a form of disease progression that affects 30% to 40% of patients.(1,2) Natural history studies show that peritoneal carcinomatosis (PC) is uniformly fatal, with median survival (not exceeding) attaining 6 months.”